|
SETD8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.72599999998169E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.26229999999284E-05 |
| Normal-vs-Stage2 |
6.735500E-02 |
| Normal-vs-Stage3 |
2.432400E-02 |
| Normal-vs-Stage4 |
2.622200E-01 |
| Stage1-vs-Stage2 |
3.855400E-01 |
| Stage1-vs-Stage3 |
9.761200E-01 |
| Stage1-vs-Stage4 |
5.110400E-01 |
| Stage2-vs-Stage3 |
5.075600E-01 |
| Stage2-vs-Stage4 |
9.863600E-01 |
| Stage3-vs-Stage4 |
6.071400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.72429999999646E-05 |
| Normal-vs-AfricanAmerican |
4.004800E-04 |
| Normal-vs-Asian |
4.706200E-01 |
| Caucasian-vs-AfricanAmerican |
8.586400E-01 |
| Caucasian-vs-Asian |
6.618400E-01 |
| AfricanAmerican-vs-Asian |
6.003600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.92159999995645E-06 |
| Normal-vs-Female |
8.587800E-04 |
| Male-vs-Female |
6.340600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.134500E-02 |
| Normal-vs-Extreme_Weight |
9.448900E-04 |
| Normal-vs-Obese |
1.806170E-04 |
| Normal-vs-Extreme_Obese |
2.369800E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.171800E-01 |
| Normal_Weight-vs-Obese |
6.657800E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.213800E-01 |
| Extreme_Weight-vs-Obese |
4.932600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.657400E-01 |
| Obese-vs-Extreme_Obese |
7.533000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.550700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.16220000001555E-06 |
| Normal-vs-Age(61-80Yrs) |
6.583600E-04 |
| Normal-vs-Age(81-100Yrs) |
7.054600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.564400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.476000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.402200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.078300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.951600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.172000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.26920000065311E-08 |
| Normal-VS-Type2 PRCC |
8.054800E-01 |
| Normal-VS-KIRP CIMP |
9.356000E-01 |
| Normal-VS-Unclassified PRCC |
1.096750E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.12819999798353E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.767790E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.419000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.486200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.211900E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
5.324400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.197800E-02 |
| Normal-vs-N1 |
2.949700E-02 |
| Normal-vs-N2 |
2.500200E-01 |
| N0-vs-N1 |
5.431400E-01 |
| N0-vs-N2 |
3.417400E-01 |
| N1-vs-N2 |
4.703600E-01 |
|
|
